KR20090074158A - 디하이드로피리딘 칼슘 길항제를 포함하는 국소성 조성물 - Google Patents

디하이드로피리딘 칼슘 길항제를 포함하는 국소성 조성물 Download PDF

Info

Publication number
KR20090074158A
KR20090074158A KR1020097004996A KR20097004996A KR20090074158A KR 20090074158 A KR20090074158 A KR 20090074158A KR 1020097004996 A KR1020097004996 A KR 1020097004996A KR 20097004996 A KR20097004996 A KR 20097004996A KR 20090074158 A KR20090074158 A KR 20090074158A
Authority
KR
South Korea
Prior art keywords
composition
alcohol
release
carbon atoms
fatty acid
Prior art date
Application number
KR1020097004996A
Other languages
English (en)
Korean (ko)
Inventor
요한 엥그블롬
비르기타 스벤슨
아네테 아브라함손
아케 린달
Original Assignee
모베르그 데르마 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0601806A external-priority patent/SE0601806A0/sv
Application filed by 모베르그 데르마 아베 filed Critical 모베르그 데르마 아베
Publication of KR20090074158A publication Critical patent/KR20090074158A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020097004996A 2006-09-01 2007-08-31 디하이드로피리딘 칼슘 길항제를 포함하는 국소성 조성물 KR20090074158A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601806-3 2006-09-01
SE0601806A SE0601806A0 (en) 2006-09-01 2006-09-01 Topical composition

Publications (1)

Publication Number Publication Date
KR20090074158A true KR20090074158A (ko) 2009-07-06

Family

ID=39136173

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097004996A KR20090074158A (ko) 2006-09-01 2007-08-31 디하이드로피리딘 칼슘 길항제를 포함하는 국소성 조성물

Country Status (6)

Country Link
US (1) US8217062B2 (de)
EP (1) EP2061463A4 (de)
JP (1) JP2010502598A (de)
KR (1) KR20090074158A (de)
CA (1) CA2662298A1 (de)
WO (1) WO2008026984A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2849727A4 (de) * 2012-05-17 2015-10-28 Contract Pharmaceuticals Ltd Nichtionische vesikelformulierungen aus calciumkanalblockern
CA3102228A1 (en) * 2018-06-01 2019-12-05 Tavanta Therapeutics Hungary Incorporated Topical amlodipine salts for the treatment of anorectal diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109036A (en) 1993-03-19 1998-12-27 Cellegy Pharamaceuticals Inc Preparations for detachment of the epithelial barrier function and use of means for the preparation of such preparations
EP1250927A3 (de) 1997-02-24 2003-03-26 S.L.A. Pharma AG Pharmazeutische Zusammensetzung enthaltend Nifedipine für eine topische Anwendung
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
WO2007004236A2 (en) * 2005-07-04 2007-01-11 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof

Also Published As

Publication number Publication date
US20100010052A1 (en) 2010-01-14
EP2061463A4 (de) 2010-01-20
CA2662298A1 (en) 2008-03-06
JP2010502598A (ja) 2010-01-28
WO2008026984A1 (en) 2008-03-06
US8217062B2 (en) 2012-07-10
EP2061463A1 (de) 2009-05-27

Similar Documents

Publication Publication Date Title
EP1941880B1 (de) Ein pyridoncarbonsäure-derivat enthaltende lotion
CN109715138B (zh) 前列环素类似物制剂
CA2416650C (en) Enhancement of the action of central and peripheral nervous system agents
TW201705960A (zh) 癸二醯雙那布扶林酯之緩釋藥物製劑
CN114344299A (zh) 一种具有长效缓释作用的脂质释药系统及其制备方法
JP4138910B2 (ja) 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
JP6219430B2 (ja) デオキシコール酸およびその塩類の製剤
KR20090074158A (ko) 디하이드로피리딘 칼슘 길항제를 포함하는 국소성 조성물
US20230059107A1 (en) Stable topical compositions of fenoldopam
KR101018819B1 (ko) 티오우레아 유도체를 함유하는 소양성 또는 자극성피부질환의 예방 또는 치료용 외용제 조성물
CA2901208A1 (en) Topical ocular analgesic agents
JP2003335663A (ja) 消炎鎮痛外用剤
JP5897299B2 (ja) ローション剤
WO2007086582A1 (ja) ２２－オキサ－１α,２５－ジヒドロキシビタミンＤ3を含有する水中油型乳剤性ローション剤およびそれを用いた皮膚疾患の治療方法
EP2193798A1 (de) Cyclosporin enthaltende pharmazeutische zusammensetzung vom flüssigkristall-emulsionstyp und verfahren zur behandlung von hautkrankheiten damit
CN115624520B (zh) 一种地奥司明乳膏剂和应用
WO2023016583A1 (zh) 一种芦可替尼组合物及其用途
JP4060347B2 (ja) ２２−オキサ−１α，２５−ジヒドロキシビタミンＤ３を含有する水中油型乳剤性ローション剤
JP6356329B2 (ja) デオキシコール酸およびその塩類の製剤
KR20240125610A (ko) Shr0302의 안정된 제형
SE0601806A0 (en) Topical composition
RU2192860C1 (ru) Мазь для лечения блефаритов и блефароконъюнктивитов
JP2024539703A (ja) デュークラバシチニブの局所製剤
JPH03118323A (ja) ９―メチル―３―（１Ｈ―テトラゾール―５―イル）―４Ｈ―ピリド［１，２―ａ］ピリミジン―４―オン又はその塩の軟膏剤
RU2538680C2 (ru) Фармацевтическая композиция для лечения атопического дерматита и способ ее получения

Legal Events

Date Code Title Description
N231 Notification of change of applicant
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid